About Geneious
Geneious is a company based in Auckland (New Zealand) founded in 2004 was acquired by Graphpad in April 2019. Geneious offers products and services including Geneious Prime and Geneious Biologics. Geneious operates in a competitive market with competitors including Helix, Benchling, Genuity Science, Inpharmatica and BioAge Labs, among others.
Products & Services of Geneious
Geneious offers a comprehensive portfolio of products and services, including Geneious Prime and Geneious Biologics.
Tools for sequence assembly, alignment, and molecular cloning analysis.
Cloud-based solution for antibody screening and data visualization.
Apps and channels of Geneious
its YouTube channel Geneious has 2.99K subscribers and 30 videos.
Videos from Geneious
The most watched videos on Geneious's YouTube channel, Geneious (2.99K subscribers). Click a video to play it here.
More on Geneious.
Funding Insights of Geneious
- Total Rounds 1
- Investors Count 2
All 1 funding rounds of Geneious with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2019 | – | Seed | – | Ice Angels, New Zealand Growth Capital Partners | – |
3 investors in total: 3 institutional.
Investors in Geneious
Geneious has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Graphpad, Icehouse Ventures and New Zealand Growth Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments are made in New Zealand startups. | 2003 | iceangels.co.nz | Auckland, New Zealand | |
Venture capital investments are targeted through managed funds of funds. | – | nzgcp.co.nz | Auckland, New Zealand | |
Cloud-based data visualization and analysis tools are supplied to scientists. | 1989 | graphpad.com | San Diego, United States |
Investor details for Geneious
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Geneious
3 dated milestones of Geneious across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Geneious is founded.
- Exit Acquired by Graphpad.
- Funding First funding round.
Competitors of Geneious
Geneious operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Benchling, Genuity Science, Inpharmatica and BioAge Labs, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| helix.com | 2015 | San Francisco, United States | $435M | – | Genomic database for clinical research is provided. | |
| benchling.com | 2012 | San Francisco, United States | $411.9M | 640 | Cloud-based bioinformatics platform is offered for biotech research. | |
| genuitysci.com | 2013 | Boston, United States | $515M | – | AI-based omics data analysis solutions are provided to researchers. | |
| inpharmatica.co.uk | 1998 | London, United Kingdom | – | 62 | Developer of predictive informatics based platform for drug discovery | |
| bioagelabs.com | 2015 | Vallejo, United States | $293.9M | 43 | Bioinformatics platform is provided for biomarkers and drug discovery. | |
| depixus.com | 2012 | Paris, France | $34.52M | – | Single-molecule genetic and epigenetic sequencing solutions are provided. | |
| genomics.com | 2014 | Oxford, United Kingdom | $115.54M | – | Genomic risk assessment and prevention platform is provided. | |
| sevenbridges.com | 2009 | Cambridge, United States | $113M | 112 | Cloud-based platform to analyze, store, and act on genomic data. |
Detailed competitors of Geneious
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Geneious
The website of Geneious (geneious.com) receives about 105.5K visits a month.
- Monthly visits105.5K
▲ 9% vs previous month
Websites whose visitors overlap most with Geneious. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| codoncode.com | 100% | – | #7,230,011 | View details | |
justbio.com | justbio.com | 100% | – | #4,232,469 | – |
| macvector.com | 100% | – | #5,246,504 | View details | |
| biomatters.com | 99% | – | – | View details | |
| bioconductor.org | 94% | – | #143,754 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Geneious
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Geneious
Complete news archive for Geneious
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Geneious
10 companies that operate in the same segment as Geneious (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Geneious
Geneious was founded in 2004 and raised its 1st funding round 15 years after it was founded.
Geneious is headquartered in Auckland, New Zealand.
Geneious was founded in 2004 in Auckland, New Zealand, as a provider of bioinformatics software. Tools are offered for the analysis and interpretation of genome sequences, supporting research in genetic variations. The platform is utilized by scientists to examine and forecast variants linked to genetic diseases, operating within the biotechnology sector focused on genomic data processing.
Geneious's top competitors include Helix, Benchling and BioAge Labs.
Geneious offers Geneious Prime and Geneious Biologics.
Geneious has 3 investors. Key investors include Graphpad, Icehouse Ventures, and New Zealand Growth Capital Partners.
Geneious operates through Biomatters Limited.
Yes. Geneious was acquired by Graphpad in April 2019.
The website of Geneious receives about 106 thousand visits a month.